ELOXX PHARMACEUTICALS INC
ELOX · NASDAQ
Updated at 2026-10-15 06:51:57
- Today's High
- $13.22
- Today’s Low
- $12.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $13.13
- Previous Close
- $12.21
- Volume
- 12.54K
- Market Cap
- $49.28M
- P/E Ratio
- --
- EPS
- $-7.06
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- P.O. BOX 274, ARLINGTON, MA, UNITED STATES, 02476
- Country
- US
- Listing Date
- 2012-11-23
- Fiscal Year End
- December
- Shares Outstanding
- 4.04M
- CIK
- 0001035354
- Website
- www.eloxxpharma.com
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is focused on developing ribonucleic acid modulator drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. The company is headquartered in Waltham, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-06-30
$0
2025-03-31
$0
Operating Expenses
2026-06-30
$4.45M
2026-03-31
$3.79M
2025-06-30
$1.58M
2025-03-31
$1.22M
Net Income
2026-06-30
-$4.5M
2026-03-31
-$3.75M
2025-06-30
-$1.89M
2025-03-31
-$1.7M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
Earnings Per Share
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$4.45M
2026-03-31
-$3.72M
2025-06-30
-$1.58M
2025-03-31
-$1.22M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
| Item | 2026-06-30 | 2026-03-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $4.45M | $3.79M | $1.58M | $1.22M |
| Net Income | -$4.5M | -$3.75M | -$1.89M | -$1.7M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | -- | -- | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$4.45M | -$3.72M | -$1.58M | -$1.22M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.